The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of iza-bren (BL-B01D1), an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with driver genomic alterations (GA) outside of classic EGFR mutations.
 
Yunpeng Yang
No Relationships to Disclose
 
Li Zhang
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Akeso Biopharma; AstraZeneca; CHINA SHIYAO PHARMA; HenRui; Roche; Sichuan Biokin Pharmaceutical
Research Funding - Akeso Biopharma (Inst); AstraZeneca (Inst); BMS (Inst); Chia Tai Tianqing Pharmaceutical Group (Inst); QiLu Pharmaceutical (Inst); Sichuan Biokin Pharmaceutical, (Inst); Sichuan Kelun-Biotech Biopharmaceutical (Inst)
 
Yuxiang Ma
No Relationships to Disclose
 
Yuanyuan Zhao
No Relationships to Disclose
 
Wenfeng Fang
No Relationships to Disclose
 
Hongyun Zhao
No Relationships to Disclose
 
Yan Huang
No Relationships to Disclose
 
Likun Chen
No Relationships to Disclose
 
Xue Hou
No Relationships to Disclose
 
Yongsheng Li
No Relationships to Disclose
 
Yongsheng Wang
No Relationships to Disclose
 
Zhiyong He
No Relationships to Disclose
 
Sa Xiao
Employment - Baili Biopharmaceutical
Stock and Other Ownership Interests - Baili Biopharmaceutical
 
Hai Zhu
Employment - Baili Biopharmaceutical (I); Systimmune; Systimmune (I)
Leadership - Baili Biopharmaceutical (I); Systimmune; Systimmune (I)
Stock and Other Ownership Interests - Baili Biopharmaceutical (I); Systimmune; Systimmune (I)
 
Yi Zhu
Employment - Baili Biopharmaceutical; SystImmune; Systimmune (I)
Leadership - Baili Biopharmaceutical; SystImmune
Stock and Other Ownership Interests - Baili Biopharmaceutical; SystImmune; SystImmune (I)